211 related articles for article (PubMed ID: 32313931)
41. Diversity and complexity in chromatin recognition by TFII-I transcription factors in pluripotent embryonic stem cells and embryonic tissues.
Makeyev AV; Enkhmandakh B; Hong SH; Joshi P; Shin DG; Bayarsaihan D
PLoS One; 2012; 7(9):e44443. PubMed ID: 22970219
[TBL] [Abstract][Full Text] [Related]
42. GTF2IRD2 from the Williams-Beuren critical region encodes a mobile-element-derived fusion protein that antagonizes the action of its related family members.
Palmer SJ; Taylor KM; Santucci N; Widagdo J; Chan YK; Yeo JL; Adams M; Gunning PW; Hardeman EC
J Cell Sci; 2012 Nov; 125(Pt 21):5040-50. PubMed ID: 22899722
[TBL] [Abstract][Full Text] [Related]
43. The role of GTF2IRD1 in the auditory pathology of Williams-Beuren Syndrome.
Canales CP; Wong AC; Gunning PW; Housley GD; Hardeman EC; Palmer SJ
Eur J Hum Genet; 2015 Jun; 23(6):774-80. PubMed ID: 25248400
[TBL] [Abstract][Full Text] [Related]
44. Cognitive-behavioral phenotypes of Williams syndrome are associated with genetic variation in the GTF2I gene, in a healthy population.
Crespi BJ; Hurd PL
BMC Neurosci; 2014 Nov; 15():127. PubMed ID: 25429715
[TBL] [Abstract][Full Text] [Related]
45. Evolution of general transcription factors.
Gunbin KV; Ruvinsky A
J Mol Evol; 2013 Feb; 76(1-2):28-47. PubMed ID: 23229069
[TBL] [Abstract][Full Text] [Related]
46. Williams Syndrome neuroanatomical score associates with GTF2IRD1 in large-scale magnetic resonance imaging cohorts: a proof of concept for multivariate endophenotypes.
Fan CC; Schork AJ; Brown TT; Spencer BE; Akshoomoff N; Chen CH; Kuperman JM; Hagler DJ; Steen VM; Le Hellard S; Håberg AK; Espeseth T; Andreassen OA; Dale AM; Jernigan TL; Halgren E;
Transl Psychiatry; 2018 Jun; 8(1):114. PubMed ID: 29884845
[TBL] [Abstract][Full Text] [Related]
47. A duplicated gene in the breakpoint regions of the 7q11.23 Williams-Beuren syndrome deletion encodes the initiator binding protein TFII-I and BAP-135, a phosphorylation target of BTK.
Pérez Jurado LA; Wang YK; Peoples R; Coloma A; Cruces J; Francke U
Hum Mol Genet; 1998 Mar; 7(3):325-34. PubMed ID: 9466987
[TBL] [Abstract][Full Text] [Related]
48. Isolation and characterization of BEN, a member of the TFII-I family of DNA-binding proteins containing distinct helix-loop-helix domains.
Bayarsaihan D; Ruddle FH
Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7342-7. PubMed ID: 10861001
[TBL] [Abstract][Full Text] [Related]
49. Variation in the Williams syndrome GTF2I gene and anxiety proneness interactively affect prefrontal cortical response to aversive stimuli.
Jabbi M; Chen Q; Turner N; Kohn P; White M; Kippenhan JS; Dickinson D; Kolachana B; Mattay V; Weinberger DR; Berman KF
Transl Psychiatry; 2015 Aug; 5(8):e622. PubMed ID: 26285132
[TBL] [Abstract][Full Text] [Related]
50. Regulation of alternative splicing of Gtf2ird1 and its impact on slow muscle promoter activity.
Tay ES; Guven KL; Subramaniam N; Polly P; Issa LL; Gunning PW; Hardeman EC
Biochem J; 2003 Sep; 374(Pt 2):359-67. PubMed ID: 12780350
[TBL] [Abstract][Full Text] [Related]
51. A transcription factor involved in skeletal muscle gene expression is deleted in patients with Williams syndrome.
Tassabehji M; Carette M; Wilmot C; Donnai D; Read AP; Metcalfe K
Eur J Hum Genet; 1999; 7(7):737-47. PubMed ID: 10573005
[TBL] [Abstract][Full Text] [Related]
52. Generation of a mouse model for a conditional inactivation of Gtf2i allele.
Enkhmandakh B; Stoddard C; Mack K; He W; Kaback D; Yee SP; Bayarsaihan D
Genesis; 2016 Jul; 54(7):407-12. PubMed ID: 27194223
[TBL] [Abstract][Full Text] [Related]
53. A mouse single-copy gene, Gtf2i, the homolog of human GTF2I, that is duplicated in the Williams-Beuren syndrome deletion region.
Wang YK; Pérez-Jurado LA; Francke U
Genomics; 1998 Mar; 48(2):163-70. PubMed ID: 9521869
[TBL] [Abstract][Full Text] [Related]
54. Loss of GTF2I promotes neuronal apoptosis and synaptic reduction in human cellular models of neurodevelopment.
Adams JW; Vinokur A; de Souza JS; Austria C; Guerra BS; Herai RH; Wahlin KJ; Muotri AR
Cell Rep; 2024 Mar; 43(3):113867. PubMed ID: 38416640
[TBL] [Abstract][Full Text] [Related]
55. Neuronal deletion of Gtf2i results in developmental microglial alterations in a mouse model related to Williams syndrome.
Bar E; Fischer I; Rokach M; Elad-Sfadia G; Shirenova S; Ophir O; Trangle SS; Okun E; Barak B
Glia; 2024 Jun; 72(6):1117-1135. PubMed ID: 38450767
[TBL] [Abstract][Full Text] [Related]
56. A Common Polymorphism in a Williams Syndrome Gene Predicts Amygdala Reactivity and Extraversion in Healthy Adults.
Swartz JR; Waller R; Bogdan R; Knodt AR; Sabhlok A; Hyde LW; Hariri AR
Biol Psychiatry; 2017 Feb; 81(3):203-210. PubMed ID: 26853120
[TBL] [Abstract][Full Text] [Related]
57. Intracisternal Gtf2i Gene Therapy Ameliorates Deficits in Cognition and Synaptic Plasticity of a Mouse Model of Williams-Beuren Syndrome.
Borralleras C; Sahun I; Pérez-Jurado LA; Campuzano V
Mol Ther; 2015 Nov; 23(11):1691-1699. PubMed ID: 26216516
[TBL] [Abstract][Full Text] [Related]
58. TFII-I regulates target genes in the PI-3K and TGF-β signaling pathways through a novel DNA binding motif.
Segura-Puimedon M; Borralleras C; Pérez-Jurado LA; Campuzano V
Gene; 2013 Sep; 527(2):529-36. PubMed ID: 23831514
[TBL] [Abstract][Full Text] [Related]
59. A small 7q11.23 microduplication involving GTF2I in a family with intellectual disability.
Pinelli M; Terrone G; Troglio F; Squeo GM; Cappuccio G; Imperati F; Pignataro P; Genesio R; Nitch L; Del Giudice E; Merla G; Testa G; Brunetti-Pierri N
Clin Genet; 2020 Jun; 97(6):940-942. PubMed ID: 32349160
[TBL] [Abstract][Full Text] [Related]
60. Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioral and myelin alterations rescuable by a remyelinating drug.
Barak B; Zhang Z; Liu Y; Nir A; Trangle SS; Ennis M; Levandowski KM; Wang D; Quast K; Boulting GL; Li Y; Bayarsaihan D; He Z; Feng G
Nat Neurosci; 2019 May; 22(5):700-708. PubMed ID: 31011227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
